Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Novartis reports positive results from Jakavi Phase III trial in patients with polycythemia vera Swiss drug-maker Novartis has reported positive results from its pivotal Phase III clinical trial of Jakavi (ruxolitinib), an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases, to treat patients with polycythemia vera (PV). Contract Research & Services > Clinical Trials > News
Applied Molecular Transport, Janssen enter research and license deal for IBS therapy By PBR Staff Writer
US-based Applied Molecular Transport (AMT) has entered into a research collaboration and license agreement with Janssen Biotech, a subsidiary of Johnson & Johnson (JNJ), for a potential inflammatory bowel diseases (IBS) therapy.
News Sorrento completes patient enrollment in Cynviloq TRIBECA registrational trial By PBR Staff Writer
US-based Sorrento Therapeutics has completed patient enrollment in its ongoing TRIBECA (TRIal establishing bioequivalence [BE] between Cynviloq and Albumin-bound paclitaxel) registrational trial.
News Sumitomo Chemical develops SumiLarv 2 MR to prevent dengue fever Sumitomo Chemical is pleased to announce that it has developed SumiLarv 2 MR, a novel, long - lasting larvicide formulation that is effective in preventing dengue fever.
News
AgeneBio secures ADDF grant for new approach to delaying onset of Alzheimer's Dementia AgeneBio, a pharmaceutical company developing innovative therapeutics for unserved patients battling amnestic mild cognitive impairment (aMCI), the pre-dementia stage of Alzheimer's disease, and other neurological and psychiatric diseases, announced that the company has received a $900,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF).
News Adamis receives notice of allowance for US and Japanese patents for dry powder inhaler Taper DPI Adamis Pharmaceuticals recently received a notice of allowance that one of its patent applications for its proprietary dry powder inhaler, Taper DPI, will issue in the United States (U.S. Patent Application No. 13/320,762) and in Japan (Japanese Patent Application No. 2012-511965).
News Goodwin, Transporin enter technology collaboration to improve ability of antibody drug conjugates Goodwin Biotechnology, a biological Contract Manufacturing Organization (CMO) that specializes in Mammalian Cell Culture expression systems and Bioconjugation technologies, and Transporin, a Silicon Valley R & D company with full ownership of IP rights to a broad array of life science and software technologies, have announced a collaboration whereby Goodwin Biotechnology has been granted a worldwide, exclusive license to utilize the proprietary metal-binding domain (MBD) of human insulin-like growth factor binding protein-3 (IGFBP-3) conjugated to monoclonal antibodies or antibody fusion proteins, and perform process development and manufacturing services using such conjugates for research, evaluation, and clinical trial purposes.
News

Latest News and Insight by Sector

Production & Manufacturing

FDA grants orphan drug status for RestorGenex' RES-529 to treat glioblastoma multiforme
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted orphan drug designation for US-based biopharmaceutical firm RestorGenex's RES-529, a first-in-class inhibitor of the PI3K/Akt/mTOR pathway, to treat glioblastoma multiforme.
News
European Commission approves GSK and Novartis' three-part transaction
By PBR Staff Writer
UK-based GlaxoSmithKline has received clearance from the European Commission (EC) for its proposed three-part transaction with Swiss drug-maker Novartis.
News

Drug Research

Sumitomo Chemical develops SumiLarv 2 MR to prevent dengue fever
Sumitomo Chemical is pleased to announce that it has developed SumiLarv 2 MR, a novel, long - lasting larvicide formulation that is effective in preventing dengue fever.
News
AgeneBio secures ADDF grant for new approach to delaying onset of Alzheimer's Dementia
AgeneBio, a pharmaceutical company developing innovative therapeutics for unserved patients battling amnestic mild cognitive impairment (aMCI), the pre-dementia stage of Alzheimer's disease, and other neurological and psychiatric diseases, announced that the company has received a $900,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF).
News

Inward Investment

Merck in talks to acquire Cubist Pharmaceuticals for nearly $8bn
By PBR Staff Writer
New Jersey-based drug giant Merck & Co is, reportedly, in talks over a potential acquisition of antibiotics maker Cubist Pharmaceuticals for more than $8bn.
News
Endo International to buy Auxilium Pharmaceuticals for $2.6bn
By PBR Staff Writer
Ireland-based Endo International has signed an agreement to acquire Auxilium Pharmaceuticals, in a deal that is worth nearly $2.6bn.
News

Packaging

Bosch expands CPS portfolio for serialization of pharmaceutical packaging
Bosch Packaging Technology, a leading supplier of process and packaging technology, has expanded its portfolio for the serialization of pharmaceutical packaging. In the fight against counterfeit drugs, many countries are about to implement legislation changes for a stricter labelling of pharmaceuticals. Consequently, drug manufacturers require safer and more flexible solutions.
News
UPS announces acquisition of Poltraf
By PBR Staff Writer
Atlanta-based UPS that offers a range of solutions for transporting packages and freight will be acquiring the pharmaceutical logistics company of Poland-based investment fund Ortie, Poltraf for an undisclosed amount.
News

Contract Research & Services

Applied Molecular Transport, Janssen enter research and license deal for IBS therapy
By PBR Staff Writer
US-based Applied Molecular Transport (AMT) has entered into a research collaboration and license agreement with Janssen Biotech, a subsidiary of Johnson & Johnson (JNJ), for a potential inflammatory bowel diseases (IBS) therapy.
News
RegeneRx, G-treeBNT form joint venture to develop RGN-259 in US
RegeneRx Biopharmaceuticals, announced that it has entered into agreements with G-treeBNT Co., to develop RGN-259 for dry eye syndrome and neurotrophic keratitis (an orphan indication) in the United States.
News

Automation

Sorrento completes patient enrollment in Cynviloq TRIBECA registrational trial
By PBR Staff Writer
US-based Sorrento Therapeutics has completed patient enrollment in its ongoing TRIBECA (TRIal establishing bioequivalence [BE] between Cynviloq and Albumin-bound paclitaxel) registrational trial.
News
Adamis receives notice of allowance for US and Japanese patents for dry powder inhaler Taper DPI
Adamis Pharmaceuticals recently received a notice of allowance that one of its patent applications for its proprietary dry powder inhaler, Taper DPI, will issue in the United States (U.S. Patent Application No. 13/320,762) and in Japan (Japanese Patent Application No. 2012-511965).
News

Regulatory Affairs

Vifor Pharma hyperphosphatemia drug Velphoro gets Swissmedic approval
By PBR Staff Writer
Vifor Pharma has received approval from the Swiss agency for Therapeutic Products (Swissmedic) for Velphoro, a non-calcium, iron-based, chewable phosphate binder, for the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis.
News
EMA committee issues positive opinion for Merck's Sivextro to treat ABSSSI
By PBR Staff Writer
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued positive opinion recommending approval for Merck's investigational antibiotic Sivextro (tedizolid phosphate) to treat acute bacterial skin and skin structure infections (ABSSSI) in adults.
News

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Reports Buy online from $250



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery